Philips North America has been the subject of 357 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for Amneal Pharmaceuticals of New York, LLC.
Amneal Pharmaceuticals of New York, LLC: 0 warning letters, 1 recall, 0 approval records, 0 Form 483s.
Philips North America: 0 warning letters, 357 recalls, 0 approval records, 0 Form 483s.
Side by side
Amneal Pharmaceuticals of New York, LLC — Warning letters0
Philips North America — Warning letters0
Amneal Pharmaceuticals of New York, LLC — Recalls1
Philips North America — Recalls357
Amneal Pharmaceuticals of New York, LLC — Approval records0
Philips North America — Approval records0
Amneal Pharmaceuticals of New York, LLC — Form 483s0
Philips North America — Form 483s0
Timeline
Cite this comparison
Pre-formatted for a story, footnote, or reference list:
"Amneal Pharmaceuticals of New York, LLC vs Philips North America: FDA Enforcement Comparison." Argus HQ, accessed October 12, 2026. https://argushq.ai/compare/amneal-pharmaceuticals-of-new-york-llc-vs-philips-north-america
Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗